Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07285044Phase 2Recruiting
Phase 2, open-label, single-arm trial in cancer, sponsored by Mayo Clinic. Primary endpoints: Patient preferences regarding location of cancer treatment delivery at 12 weeks, Adverse Events Related to Location of Treatment at 9 months and 1 more. Started Dec 2025; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07285044.